NASDAQ:VECT
Delisted

Vectivbio Holding Ag Stock Signals

etoro logo Buy VECT
*Your capital is at risk
$16.85
+0 (+0%)
At Close: Oct 06, 2023

Latest Data & Signals Issued

Below are some of the latest signals issued for VectivBio Holding AG

General

Signal Type Signal Value Data
Score 0.000 119 days ( -97.31 %
Last Price $16.85 0 %
Performance History
7 Days
$16.85 $16.85
0%
30 Days
$16.85 $16.85
0%
12 Mos
$6.94 $16.85
142.80%

6/18

Active Buy Signals

Specific Signals

Short Term
Net score: 20.95
Signal Type Signal Value Importance Data
High / Low N/A Very Low $16.85 - $16.85
Trend - 3 mos 0 % High Width: 0 %
Pred. range - 3 mos N/A - N/A Low -100.00 % - -100.00 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Oct 05, 2023 - 2 days
RSI Short Pivot Signal Buy Very Low Jul 18, 2023 - 57 days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days
Short/Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 51.57
Signal Type Signal Value Importance Data
Trend - 12 mos 155.02 % Very High Width: 44.34 %
Pred. range - 12 mos $36.41 - $52.55 High 116.06 % - 211.86 %
Short MA 12 mos Sell Very High Jun 30, 2023 - 68 days
Long MA 12 mos Sell Very High Apr 14, 2023 - 121 days
Short/Long MA 12 mos Buy Very High Apr 05, 2023 - 127 days
Pivot Long Sell Low Jun 27, 2023 - 71 days
RSI Long Pivot Signal Buy Low Jul 27, 2023 - 50 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT VECTIVBIO HOLDING AG
VectivBio Holding AG
VectivBio Holding AG, a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for treatments of severe rare conditions. It develops apraglutide, a long-acting synthetic peptide analog of glucagon-like peptide-2 that is in Phase III clinical trial for the treatment of patients with short bowel syndrome-intestinal failure (SBS-IF), as well as apraglutide is in Phase II clinical trial for...
GOLDEN STAR
Ticker Change Signal Date

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE